Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Erika Bandini

Showing results (21-30 of 26) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 26 results.
Cell Death & Disease|March 29, 2025
Gastroesophageal circulating tumor cell crosstalk with peripheral immune system guides CTC survival and proliferationTania Rossi, Martina Valgiusti, Maurizio Puccetti, et al.
Journal of Experimental & Clinical Cancer Research : CR|February 1, 2021
Distinct profile of CD34<sup>+</sup> cells and plasma-derived extracellular vesicles from triple-negative patients with Myelofibrosis reveals potential markers of aggressive diseaseDorian Forte, Martina Barone, Cristina Morsiani, et al.
International Journal of Molecular Sciences|March 29, 2019
Role of SIRT-3, p-mTOR and HIF-1α in Hepatocellular Carcinoma Patients Affected by Metabolic Dysfunctions and in Chronic Treatment with MetforminSerena De Matteis, Emanuela Scarpi, Anna Maria Granato, et al.
The Oncologist|May 8, 2025
Exploring the promoter regions of cancer predisposition genes in patients with triple-negative breast cancer reveals the presence of rare germline variantsMichela Palleschi, Alessandra Virga, Emanuela Scarpi, et al.
Nature Communications|November 29, 2017
Transcribed ultraconserved region 339 promotes carcinogenesis by modulating tumor suppressor microRNAsIvan Vannini, Petra M Wise, Kishore B Challagundla, et al.
Nature Communications|January 10, 2018
Publisher Correction: Transcribed ultraconserved region 339 promotes carcinogenesis by modulating tumor suppressor microRNAsIvan Vannini, Petra M Wise, Kishore B Challagundla, et al.
Pageof 3

Showing results (21-30 of 26) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 26 results.
Cell Death & Disease|March 29, 2025
Gastroesophageal circulating tumor cell crosstalk with peripheral immune system guides CTC survival and proliferationTania Rossi, Martina Valgiusti, Maurizio Puccetti, et al.
Journal of Experimental & Clinical Cancer Research : CR|February 1, 2021
Distinct profile of CD34<sup>+</sup> cells and plasma-derived extracellular vesicles from triple-negative patients with Myelofibrosis reveals potential markers of aggressive diseaseDorian Forte, Martina Barone, Cristina Morsiani, et al.
International Journal of Molecular Sciences|March 29, 2019
Role of SIRT-3, p-mTOR and HIF-1α in Hepatocellular Carcinoma Patients Affected by Metabolic Dysfunctions and in Chronic Treatment with MetforminSerena De Matteis, Emanuela Scarpi, Anna Maria Granato, et al.
The Oncologist|May 8, 2025
Exploring the promoter regions of cancer predisposition genes in patients with triple-negative breast cancer reveals the presence of rare germline variantsMichela Palleschi, Alessandra Virga, Emanuela Scarpi, et al.
Nature Communications|November 29, 2017
Transcribed ultraconserved region 339 promotes carcinogenesis by modulating tumor suppressor microRNAsIvan Vannini, Petra M Wise, Kishore B Challagundla, et al.
Nature Communications|January 10, 2018
Publisher Correction: Transcribed ultraconserved region 339 promotes carcinogenesis by modulating tumor suppressor microRNAsIvan Vannini, Petra M Wise, Kishore B Challagundla, et al.
Pageof 3